Home > About Xigen : Business Strategy  

Business Strategy

Xigen business model is based on the development and commercialisation of new therapeutic peptides through partnerships with pharma companies.
To achieve this goal, Xigen’s approach is to surround itself with dedicated and recognized professionals and international experts in drug development and inflammation in order to reach the demonstration of safety and clinical efficacy of drug candidates in the most expedite way.